Emerging roles of GLIS3 in neonatal diabetes, type 1 and type 2 diabetes
Authors:
- 1 February 2017
- journal article
- review article
- Published by Bioscientifica in Journal of Molecular Endocrinology
- Vol. 58 (2) , R73-R85
Abstract
GLI-similar 3 (GLIS3), a member of the Krüppel-like zinc finger protein subfamily, is predominantly expressed in the pancreas, thyroid and kidney. Glis3 mRNA can be initially detected in mouse pancreas at embryonic day 11.5 and is largely restricted to β cells, pancreatic polypeptide-expressing cells, as well as ductal cells at later stage of pancreas development. Mutations in GLIS3 cause a neonatal diabetes syndrome, characterized by neonatal diabetes, congenital hypothyroidism and polycystic kidney. Importantly, genome-wide association studies showed that variations of GLIS3 are strongly associated with both type 1 diabetes (T1D) and type 2 diabetes (T2D) in multiple populations. GLIS3 cooperates with pancreatic and duodenal homeobox 1 (PDX1), v-maf musculoaponeurotic fibrosarcoma oncogene family, protein A (MAFA), as well as neurogenic differentiation 1 (NEUROD1) and potently controls insulin gene transcription. GLIS3 also plays a role in β cell survival and likely in insulin secretion. Any perturbation of these functions may underlie all three forms of diabetes. GLIS3, synergistically with hepatocyte nuclear factor 6 (HNF6) and forkhead box A2 (FOXA2), controls fetal islet differentiation via transactivating neurogenin 3 (NGN3) and impairment of this function leads to neonatal diabetes. In addition, GLIS3 is also required for the compensatory β cell proliferation and mass expansion in response to insulin resistance, which if disrupted may predispose to T2D. The increasing understanding of the mechanisms of GLIS3 in β cell development, survival and function maintenance will provide new insights into disease pathogenesis and potential therapeutic target identification to combat diabetes.Keywords
This publication has 74 references indexed in Scilit:
- Sustained expression of the transcription factor GLIS3 is required for normal beta cell function in adultsEMBO Molecular Medicine, 2012
- Large-scale association analysis provides insights into the genetic architecture and pathophysiology of type 2 diabetesNature Genetics, 2012
- Meta-analysis of genome-wide association studies identifies eight new loci for type 2 diabetes in east AsiansNature Genetics, 2011
- The Krüppel-like zinc finger protein GLIS3 transactivates neurogenin 3 for proper fetal pancreatic islet differentiation in miceDiabetologia, 2011
- Modulation of the Transactivation Function and Stability of Krüppel-like Zinc Finger Protein Gli-similar 3 (Glis3) by Suppressor of FusedJournal of Biological Chemistry, 2011
- New genetic loci implicated in fasting glucose homeostasis and their impact on type 2 diabetes riskNature Genetics, 2010
- Genome-wide association study and meta-analysis find that over 40 loci affect risk of type 1 diabetesNature Genetics, 2009
- Functional analysis of the zinc finger and activation domains of Glis3 and mutant Glis3(NDH1)Nucleic Acids Research, 2008
- Sox9 coordinates a transcriptional network in pancreatic progenitor cellsProceedings of the National Academy of Sciences, 2007
- Towards a proteome-scale map of the human protein–protein interaction networkNature, 2005